PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

Table 2 Demographics, PH etiology and PH specific therapies. PAH pulmonary arterial hypertension, PH pulmonary hypertension

	N = 1073	%
Gender
Female	839	78.2
Male	228	21.2
No answer	6	0.6
PH etiology
Idiopathic PAH	416	38.8
Heritable/genetic PAH	80	7.5
Drug related PAH	15	1.4
Liver disease related PAH	16	1.5
Connective tissue disease related PAH	93	8.7
Congenital heart malformation related PAH	208	19.4
Chronic thromboembolic PH	161	15.0
Other	13	1.2
I do not know/I am not sure/Do not want to answer	71	6.6
Treatments
Oral	934	87.0
Intravenous	76	7.1
Subcutaneous	77	7.2
Inhaled	72	6.7
Study medication	18	1.7
No specific PH treatment reported	115	10.7

ISSN: 1750-1172